Bloomsbury Publishing (LON:BMY – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at Berenberg Bank in a report released on Thursday, Digital Look reports. They presently have a GBX 825 price objective on the stock. Berenberg Bank‘s price target suggests a potential upside of 27.12% from the stock’s current price.
Bloomsbury Publishing Stock Performance
BMY stock traded up GBX 30 on Thursday, reaching GBX 649. The company’s stock had a trading volume of 335,510 shares, compared to its average volume of 1,020,745. Bloomsbury Publishing has a 52 week low of GBX 435 and a 52 week high of GBX 695. The company has a market capitalization of £524.67 million, a P/E ratio of 19.79 and a beta of 0.42. The firm has a fifty day moving average of GBX 640.48 and a two-hundred day moving average of GBX 593.59. The company has a debt-to-equity ratio of 10.41, a current ratio of 1.58 and a quick ratio of 1.04.
Bloomsbury Publishing (LON:BMY – Get Free Report) last posted its earnings results on Thursday, October 22nd. The company reported GBX 16.82 EPS for the quarter. Bloomsbury Publishing had a return on equity of 9.42% and a net margin of 6.35%. As a group, analysts predict that Bloomsbury Publishing will post 2530.00 EPS for the current fiscal year.
About Bloomsbury Publishing
Bloomsbury Publishing Plc publishes academic, educational, and general fiction and non-fiction books for children, teachers, students, researchers, and professionals worldwide. The company offers books and digital resources to international research community and higher education students; online law, accounting, and tax services for the United Kingdom and professionals; and publishing services for corporations and institutions. It serves communities of interest in sports and sports science, nautical, military history, natural history, arts and crafts, and popular science; and offers books for students of the arts, humanities, and social sciences.
Read More
- Five stocks we like better than Bloomsbury Publishing
- Lockheed Martin’s F-35 Deal Could Change How Wall Street Values the Stock
- Merck and Moderna’s Cancer Vaccine Worked—Who Gets Paid?
- Intel’s $155 Price Target Raises a Bigger Question About Its Turnaround Potential
- AST SpaceMobile Faces Launch Risks as SpaceX Raises the Competitive Stakes
Receive News & Ratings for Bloomsbury Publishing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bloomsbury Publishing and related companies with MarketBeat.com's FREE daily email newsletter.
